{"nct_id":"NCT06750289","title":"Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-03-28","start_date_type":"ACTUAL","primary_completion_date":"2027-11-02","primary_completion_date_type":"ESTIMATED","completion_date":"2027-11-02","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}